May 17, 2024

Report Wire

News at Another Perspective

Ranvir Shorey exams COVID-19 unfavourable, thanks followers for his or her good needs

2 min read

Image Source : INSTAGRAM/RANVIR SHOREY Ranvir Shorey exams Covid unfavourable
Bollywood actor Ranvir Shorey has examined unfavourable for Covid-19. The actor took to Twitter on Thursday to share the information together with his followers and followers and thanked them for needs and prayers. “Happy to say I have tested negative for Covid after a week of quarantining and treatment. Thank you all for the good wishes,” Ranvir tweeted. The involved netizens have been glad to listen to the information of the actor’s restoration however warned him concerning the results brought on by the lethal virus even after testing unfavourable.
The followers urged Ranvir to take essential precautions and abide by a nutritious diet. “Yayyyyyy…. But please do take care.. There will be weakness.. Take rest for one week more. Eat well and have coconut water!” wrote a person as she expressed her happiness over the information. While one other mentioned, “Stay safe stay healthy stay witty. Always good wishes for you sir.”
Take a have a look at his submit right here

Earlier, Ranvir mentioned he has examined constructive for coronavirus and was beneath quarantine. The 48-year-old actor took to Twitter to tell followers and followers concerning the prognosis. “I have tested positive for #COVID19. Symptoms are mild. Am quarantining,” Shorey wrote. 

The actor additionally took to Twitter and revealed that it was not the Covid however the outcomes that was killing him then. 
“It’s not the Covid, it’s the wait for the test results that’s killing me right now,” Ranvir wrote sharing a Mr. Bean meme. 

The actor had a packed 2020, that includes in movies like ‘Angrezi Medium’, ‘Lootcase’, ‘Kadakh’, and collection similar to ‘PariWar’ and ‘High’. While Ranvir options within the just lately launched second season of the net collection Metro Park. He performs the favored character Kalpesh Patel.

Copyright © 2024 Report Wire. All Rights Reserved